Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
National Research Center for Women & Families, Washington, DC, USA; mt@center4research.org.
Mishka
M
Terplan
Diana
D
Zuckerman
D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D017373:Cyproterone Acetate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D011372:Progestins / Q000009:adverse effects*; D054556:Venous Thromboembolism / Q000139:chemically induced*
D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D011372:Progestins; D017373:Cyproterone Acetate
oral contraceptives